Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

IFOSFAMIDE vs IMBRUVICA: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

IFOSFAMIDE vs IMBRUVICA: Safety Overview

Metric IFOSFAMIDE IMBRUVICA
Total FAERS Reports 17,004 242
Deaths Reported 3,365 74
Death Rate 19.8% 30.6%
Hospitalizations 5,230 125
Average Patient Age 36.2 yrs 72.1 yrs
% Female Patients 41.7% N/A
FDA Approval Date Apr 4, 2007 N/A
Manufacturer Baxter Healthcare Corporation N/A
Route INTRAVENOUS N/A
Marketing Status Prescription N/A